Dm Pharma Mkt Pvt. Ltd.

Name

Dm Pharma Mkt Pvt. Ltd.

Legal name

DM Pharma Marketing Pvt. Ltd.

Website

https://dmpharmachd.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industries

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Pharmaceutical manufacturing
• PCD pharma franchise
• Contract manufacturing services
• Generic pharmaceutical products
• Pharmaceutical distribution

Headquarters

HQ city

Chandigarh

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Infrastructure, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. PCD Pharma Franchise Revenue: DM Pharma generates revenue by recruiting PCD (Propaganda Cum Distribution) franchise partners across India who receive monopoly rights to distribute pharmaceutical products in their exclusive territories. Franchise partners purchase products from DM Pharma at competitive prices and sell to retailers, hospitals, and healthcare institutions. The company offers 300+ DCGI-approved pharmaceutical products across diverse therapeutic categories.
2. Third-Party/Contract Manufacturing Services: DM Pharma provides manufacturing services for leading MNCs from its three manufacturing units located in Baddi — DM Pharma Pvt. Ltd., Saar Biotech, and Smayan Healthcare. The company manufactures pharmaceutical formulations in various forms including tablets, capsules, soft gels, syrups, injections, powders, ointments, sachets, oils, and dry syrups for third-party clients.
3. Direct Product Sales: Revenue from direct sales of 300+ pharmaceutical products to medical distributors and retailers across India through an efficient supply network. Products span therapeutic categories including antibiotics, gynecology, nutraceuticals, dermatology, pediatrics, orthopedics, and Ayurvedic formulations sold at competitive and affordable prices.
4. Export Revenue: International sales through exports to Nepal, Afghanistan, Australia, Ukraine, United Kingdom, Azerbaijan, and Sri Lanka, expanding the company's market reach beyond domestic borders.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

DM Pharma Marketing Pvt. Ltd. manufactures and distributes 300+ DCGI-approved pharmaceutical products across antibiotics, gynecology, nutraceuticals, dermatology, pediatrics, orthopedics, and Ayurvedic formulations. The company's primary commercial offering is a PCD (Propaganda Cum Distribution) pharma franchise program that grants monopoly-based exclusive distribution rights to regional partners across India, supported by three WHO and GMP-certified manufacturing units in Baddi. It also provides third-party/contract manufacturing services to leading MNCs and exports to 7+ countries.

Product overview

DM Pharma Marketing Pvt. Ltd. operates as a PCD Pharma Franchise company offering 300+ pharmaceutical products across four manufacturing divisions (DM Pharma, Dsynec Pharma, Anglica Healthcare, and HD Pharmaceuticals) plus new PSR and ANTIQUE divisions. The company manufactures products across all major formulation types including tablets, capsules, softgels, syrups, injections, powders, ointments, sachets, oils, and dry syrups. Core offerings include the PCD Pharma Franchise monopoly-based distribution model alongside individual pharmaceutical products spanning therapeutic categories such as antibiotics (DIXIM-200, DIXIM-SB, AMID 500, ACCLOR-SP), pain management (DCLO PLUS, DCLO SPRAY), cold and flu (F2M COLD+), neuropathic care (NAIF-NP, BODMIN-P, BODMIN-GP, NEUROHUB), nutritional supplements (PROQ PLUS, VITAMIX-L), oral care (DEX-DENT, LIMBACT), gynecological products (A2 TONE SYP), and antiparasitics (ABOZE-PLUS). The company also produces Ayurvedic/herbal wellness products and respiratory care items (ACBO-PHYLLIN). Products are distributed through exclusive regional franchise partners across India.

Differentiator

Problem solved

Functional benefit

Brands

• DM Pharma: Main division established in 2007 known for quality manufacturing and trusted PCD services.
• Dsynec Pharma
• Anglica Healthcare
• HD Pharmaceuticals
• PSR
• ANTIQUE

Products and services

• PCD Pharma Franchise Monopoly-based PCD pharma franchise opportunity enabling regional distributors and pharma professionals to market and sell 300+ pharmaceutical products exclusively in designated territories across India, with company-provided promotional support, competitive pricing, and dedicated assistance.
• Third-Party / Contract Manufacturing Services Contract manufacturing services for leading multinational pharmaceutical companies producing pharmaceutical formulations in tablets, capsules, soft gels, syrups, injections, powders, ointments, sachets, oils, and dry syrups across multiple therapeutic categories from three WHO and GMP-certified manufacturing units in Baddi.
• Pharmaceutical Product Catalog

Quantifiable outcome

• Serving over 1500 customers monthly across India with 300+ pharmaceutical products
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• Saar BiotechcoreStrategic or Co-development PartnerSaar Biotech is one of three dedicated manufacturing units operated by DM Pharma Marketing Pvt. Ltd. in Baddi. It operates as part of the company's integrated manufacturing infrastructure, producing pharmaceutical products that are distributed through the PCD franchise network. Saar Biotech contributes to the company's total production capacity of 2000+ brands per month.
• Smayan HealthcarecoreStrategic or Co-development PartnerSmayan Healthcare is one of three dedicated manufacturing units in Baddi operated under the DM Pharma Marketing Pvt. Ltd. umbrella. The facility produces pharmaceutical formulations alongside DM Pharma Pvt. Ltd. and Saar Biotech, enabling the company to maintain consistent quality and production excellence across its portfolio of 300+ pharmaceutical products.
• DM Pharma Pvt. Ltd.coreStrategic or Co-development PartnerDM Pharma Pvt. Ltd. is one of three manufacturing units operated in Baddi, forming the production backbone of DM Pharma Marketing Pvt. Ltd. Together with Saar Biotech and Smayan Healthcare, it enables the company to produce 2000+ brands per month across multiple therapeutic segments including dermatology, orthopedics, cardiology, nutraceuticals, gynecology, and digestive enzymes.
• 1500+ Distribution Partners Across IndiacoreChannel Partner/ Reseller/ DistributorDM Pharma Marketing Pvt. Ltd. has built a strong network of 1500+ direct and indirect distribution partners across India. These partners operate under the PCD pharma franchise model with monopoly rights in their respective territories, distributing the company's 300+ pharmaceutical products to retailers, hospitals, and healthcare institutions nationwide.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Cipla: One of India's largest pharma manufacturers with extensive generics, respiratory, and chronic therapy portfolios plus global export reach. Relevant comparison on therapeutic breadth, Indian manufacturing scale, and regulatory certifications.
• Ajanta Pharma: Established Indian specialty generics manufacturer with operations across multiple therapeutic categories and export markets. Comparable product portfolio breadth and Indian manufacturing base.
• Alkem Laboratories: Established Indian pharma major manufacturing generics and specialty products across antibiotics, anti-infectives, and chronic therapy segments. Overlaps with DM Pharma on therapeutic breadth and Indian manufacturing footprint.
• Torrent Pharmaceuticals: Major Indian pharma company with a wide generics portfolio and significant chronic and acute therapy segments. Overlaps with DM Pharma on Indian manufacturing, multi-therapeutic coverage, and international exports.
• Ipca Laboratories: Indian pharma manufacturer with APIs and finished formulations across pain, anti-infectives, and cardiology. Direct overlap with DM Pharma on multi-formulation manufacturing for domestic and export markets.

Direct peers

• Suven Pharmaceuticals: India-based CDMO serving global pharma clients with API and intermediate manufacturing. Comparable to DM Pharma's third-party manufacturing business targeting leading MNC pharma companies from Indian GMP-certified facilities.
• Windlas Biotech: Indian contract development and manufacturing organization focused on generics formulations across multiple dosage forms. Direct competitor for third-party manufacturing contracts with similar multi-formulation capabilities.
• Akums Drugs & Pharmaceuticals: Large Indian CDMO offering contract manufacturing services and a wide range of finished dosage forms across therapeutic segments. Comparable to DM Pharma's third-party manufacturing arm serving MNC clients and its multi-formulation manufacturing capabilities.
• Macleods Pharmaceuticals: India-based mid-sized pharma manufacturer with a broad generics portfolio and active PCD franchise and third-party manufacturing operations. Direct overlap with DM Pharma on small-molecule generic manufacturing and franchise-led distribution across therapeutic categories.
• Mankind Pharma: One of India's largest PCD pharma franchise networks with extensive manufacturing and a multi-therapeutic generics portfolio. Operates a near-identical franchise-distribution model targeting regional distributors with monopoly rights.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/dmpharmachd
• Facebookfacebook.com/dmpharmamachd
• LinkedInlinkedin.com/company/dm-pharma-marketing-pvt-ltd
• Pinterestin.pinterest.com/dmpharmachd

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dm Pharma Mkt Pvt. Ltd.